Second fusion inhibitor.
D000818:Animals; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D017322:Clinical Trials, Phase II as Topic; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D010446:Peptide Fragments / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D010446:Peptide Fragments